Biogen Stock

BIIB Stock Is Primed for Higher Prices The markets are absolutely on fire and the indices are consistently forging new highs. The biotechnology sector has been lagging behind the major market indices because this sector has yet to move beyond its highs set in 2015. As of late, this…

BIIB Stock Exhibiting Bullish Tendencies My admiration for biotechnology stocks should be no surprise because I have been focusing on a number of companies within this space. This sector has once again whetted the appetite of investors, and as result, it is currently outperforming its peers. I am…

BIIB Stock: Next Stage of Bull Market Has Begun The day that I thought would never come has finally arrived. As result, I'm ecstatic to be able to explain what transpired on the Biogen stock chart this week. I’m sure the title of this article has already given…

BIIB Stock: This Trigger Will Set the Wheels in Motion I am watching Biogen Inc (NASDAQ:BIIB) stock like a hawk, because I'm inclined to believe that this biotech stock is on the verge of breaking out to the upside. This breakout would set the wheels in motion to send BIIB…

BIIB Stock Is Bottom Fishing It has been a rough ride for Biogen Inc (NASDAQ:BIIB) stock and its investors after the shares peaked at $442.29 in March 2015. In the months that followed, Biogen stock lost 53.5% of its value when it hit a low of $205.43. Ever…

BIIB Stock: Awaiting the Bull I have been patiently waiting for a bull market to begin in Biogen Inc (NASDAQ:BIIB) stock. I got my hopes up after the United States presidential election results revealed that Donald Trump was the victor, and BIIB stock—and the entire biotech sector—surged in…

BIIB Stock: Unexpected Sell-Off Biogen Inc (NASDAQ:BIIB) stock is down 5.91% on the back of news surrounding a clinical drug failure from one of its competitors, Eli Lilly and Co (NYSE:LLY). Even though this news is not directly related to Biogen Inc, investors in BIIB stock fear that that…

BIIB Stock: Election Catalyst Biogen Inc (NASDAQ:BIIB) stock has been halved, as the biotech space has been under duress and the selling-pressure catalyst has been the United States presidential election. Both presidential candidates have pledged to crack down on the alleged price gouging that biotech companies have been accused…

BIIB Stock: More Than Just Buyout Speculation Biogen Inc (NASDAQ:BIIB) stock originally popped after rumours hit the mill that a buyout was in the making. Even though the news that followed trumped that idea as Allergan, Inc. denied those rumours, BIIB stock still managed to hold the gains.…

Biogen Still Soaring Thanks to Alzheimer Breakthrough If you’ve contemplated investing in biotech, Biogen Inc (NASDAQ:BIIB) certainly makes the case for this buoyant sector. Biogen stock has gained over 11% in the past six months after a bearish phase. Just over a year ago, BIIB stock hit its…

Biogen Stock Could Benefit from Bidding War The takeover rumors surrounding Biogen Inc (NASDAQ:BIIB) are not going away; instead, they are getting stronger. It seems it’s not just Merck & Co., Inc. (NYSE:MRK) and Allergan plc (NYSE:AGN) that have shown interest in buying out the company. The combined…

BIIB Stock: More Than Just Rumors Biogen Inc (NASDAQ:BIIB) stock has been the subject of buyout rumors. This has caused some price volatility, to say the least. On August 2, shares of BIIB stock surged 9.3%, based on these speculative rumors. On August 3, we saw a drop…

Biogen Inc Has Something the Pharma Majors Want Biogen Inc (NASDAQ:BIIB) lost some 10% in one trading day last June. In fact, Biogen stock dropped to its lowest price of the year—$224.60 on June 24. That happened as the company admitted that lab tests of its new multiple…

Don’t Give Up on BIIB Stock Biogen Inc (NASDAQ:BIIB) stock suffered a major blow on June 7. There is no doubt of that, as Biogen stock dropped some 10% in a single trading session and almost 40% from its peaks. Biogen stock had already lost 5.39% of its…